MAGELLAN LONGEVITY
HomeNutraceuticals & Cellular Energizers › NOVOS Vital Organ Support

NOVOS Vital Organ Support

Written and medically reviewed by , physiatrist · Last reviewed · How we grade
In one paragraph

NOVOS Vital Organ Support, graded Emerging-evidence on Magellan — nattokinase and vinegar/acetic acid show mixed results: a large 3-year RCT found no effect of nattokinase on subclinical atherosclerosis, while smaller trials and meta-analyses report modest blood-pressure reductions (a 2023 meta-analysis of six RCTs found about 3 mmHg systolic) and improved post-meal glucose.

Source: The Journals of Gerontology: Series A 2022, PMID 35975308 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: medium

Nutraceuticals & Cellular Energizers25 PubMed citations
$69.00 typical listed price — check the live price on Amazon
View NOVOS Vital Organ Support on Amazon ↗   Open in the Magellan store →

What it is

NOVOS Vital is a multi-ingredient gummy supplement marketed for whole-body organ support, combining seven food-derived compounds: lutein and zeaxanthin (xanthophyll carotenoids concentrated in the retina and brain), nattokinase (a fibrinolytic enzyme from fermented soybeans/natto), inulin (a prebiotic fermentable fiber), apple cider vinegar (a source of acetic acid), rutin (a flavonoid), and trehalose (a disaccharide that can induce autophagy). Each ingredient acts through a distinct, well-characterized mechanism rather than a single shared pathway. The formulation is aimed at organs that commonly decline with age, including the eyes, brain, heart, kidneys, liver, muscles, and gut.

Its role in longevity

The individual ingredients carry uneven levels of human evidence. Lutein and zeaxanthin are the best supported, with large trials (AREDS2) and RCTs linking them to eye and cognitive health, though some endpoints were null (the AREDS2 primary AMD endpoint and macular-pigment change in the LIMPIA trial). Nattokinase and vinegar/acetic acid show mixed results: a large 3-year RCT found no effect of nattokinase on subclinical atherosclerosis, while smaller trials and meta-analyses report modest blood-pressure reductions (a 2023 meta-analysis of six RCTs found about 3 mmHg systolic) and improved post-meal glucose; inulin has meta-analytic support for glycemic control in prediabetes and type 2 diabetes. Rutin and trehalose are supported mainly by mechanistic and preclinical (endothelial, autophagy) data, and trehalose - the formulation's flagship brain-health ingredient - was well tolerated but showed no efficacy in its largest human test to date, the HEALEY ALS platform trial. No trial has tested this exact seven-ingredient combination, and gummy doses may sit below studied doses, so benefits are inferred from each compound separately. This evidence describes the underlying compounds and mechanisms, not this specific commercial product.

The research

Peer-reviewed studies on the active compound — citations link to PubMed.

“GlyNAC supplementation in older adults improved glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, and multiple hallmarks of aging.”
The Journals of Gerontology: Series A 2022 · PMID 35975308
“Vitamin D supplementation was associated with a reduction in cancer mortality but not all-cause or cardiovascular mortality in this meta-analysis of randomised controlled trials.”
BMJ 2019 · PMID 31405892
“vitamin D administered daily reduced cancer mortality by 12 percent”
Ageing Res Rev 2023 · PMID 37004841
“Addition of lutein + zeaxanthin, DHA + EPA, or both to the AREDS formulation in primary analyses did not further reduce risk of progression to advanced AMD. However, because of potential increased incidence of lung cancer in former smokers, lutein + zeaxanthin could be an appropriate carotenoid substitute in the AREDS formulation.”
JAMA 2013 · PMID 23644932
“Early functional abnormalities of the central retina in the early AMD patients could be improved by lutein and zeaxanthin supplementation. These improvements may be potentially attributed to the elevations in MPOD.”
Am J Ophthalmol 2012 · PMID 22835510
“Higher dietary intake of multiple nutrients, including minerals, vitamins, and carotenoids, is associated with decreased risk of progression to late AMD.”
Ophthalmology 2020 · PMID 32858063

Research describes the active mechanism and is not a claim about this specific product.

Educational information, not medical advice. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if pregnant, nursing, or taking medication.

More in Nutraceuticals & Cellular Energizers

Omega-3 EPA/DHA Fish Oil

Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…

Creatine Monohydrate

Across meta-analyses and randomized trials, creatine monohydrate combined with…

Astaxanthin Softgels

In humans, randomized trials and meta-analyses most consistently show that astaxanthin…

Zinc Picolinate

Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…

See all Nutraceuticals & Cellular Energizers →

FAQ

Does NOVOS Vital Organ Support have scientific evidence?

Yes — its active compound is linked to 25 peer-reviewed studies, summarized and cited above.

Where can I buy NOVOS Vital Organ Support?

You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.

Is NOVOS Vital Organ Support safe?

Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.